Artri Ajo King Tablets Contain Undeclared Prescription Medicines
Summary
TGA Laboratory testing identified Artri Ajo King tablets as containing undeclared diclofenac and dexamethasone, both prescription-only medicines in Australia. The TGA has issued a safety advisory warning consumers to stop using the product and is coordinating with the Australian Border Force to seize and destroy shipments at the border. Supply of these products without declared prescription medicines is illegal under Australian therapeutic goods legislation.
What changed
TGA laboratory testing detected diclofenac and dexamethasone in Artri Ajo King tablets without declaration on the product label. Both substances are prescription-only medicines in Australia. The product, marketed as a herbal joint supplement, has not been assessed by TGA for quality, safety or efficacy. Supplying products containing undisclosed prescription medicines is illegal under Australian therapeutic goods legislation.
Affected parties should immediately cease use and dispose of Artri Ajo King tablets at a pharmacy. Healthcare providers may encounter patients who have used this product and should be aware of the undisclosed prescription medicines. Importers and distributors should note TGA's coordination with Australian Border Force to seize and destroy intercepted shipments at the border. The presence of hidden active ingredients increases risk of adverse drug interactions and contraindications.
What to do next
- Stop using Artri Ajo King tablets immediately
- Return any remaining product to a local pharmacy for safe disposal
- Consult healthcare practitioner if concerned about side effects
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Artri Ajo King tablets
Safety advisory Published
16 April 2026
- Listen
- Share
The TGA Laboratory has tested a product labelled Artri Ajo King and found that the tablets contained undeclared medicines diclofenac and dexamethasone.
Both diclofenac and dexamethasone are prescription-only medicines in Australia and when taken either alone or in combination with other medicines, can cause serious side effects.
These risks increase with prolonged or repeated use.
Because these medicines are not declared on the product label, consumers may not realise they are taking prescription medicines. This increases the chance of dangerous drug interactions, contraindications and unexpected side effects.
This sample of Artri Ajo King tablets is similar to Artri King tablets tested previously and a safety advisory was published in 2024. Both products contain undeclared diclofenac and dexamethasone.
Artri Ajo King tablets have not been assessed by the TGA for quality, safety or efficacy. Supplying products that contain undisclosed diclofenac and dexamethasone, such as Artri Ajo King tablets, is illegal under Australian therapeutic goods legislation.
We urge consumers to exercise extreme caution when buying medicines and medical devices online including through social media and other digital platforms.
Products purchased over the internet:
- may be fake
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety, and efficacy as those approved by us for supply in Australia.
Information for consumers
- Stop using Artri Ajo King tablets and take any remaining product to your local pharmacy for safe disposal.
- If you have any concerns arising from your use of this product, consult your health care practitioner.
- If you suspect you have had a side effect (also known as an adverse event) to this or a similar medicine, report it to the TGA.
Action we are taking
We are working with the Australian Border Force (ABF) to help stop future shipments of Artri Ajo King from entering Australia.
We will notify ABF to seize and destroy any of these products intercepted at the border.
Report counterfeit medicines and medical devices
If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:
| Phone: | 1800 020 653 |
| Online: | Report a problem or side effect |
| Email: | info@tga.gov.au |
Topics
- Compliance and enforcement
- Import and export
- Safety monitoring and information
Product types
- Prescription medicines
- Unapproved therapeutic goods
Get daily alerts for TGA Australia Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from TGA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when TGA Australia Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.